Davis Polk
Andrzej O’Leary
- Deals
- 1
- Latest
- Jan 2026
Firm
- Davis Polk Law firm · 2025–2026 · 2 deals
Often works with
- David R. Bauer 1 deal together
- Samantha Lefland 1 deal together
- William A. Curran 1 deal together
- Jesse Solomon 1 deal together
- Matthew Yeowart 1 deal together
- Meytal McCoy 1 deal together
Deals
US deals dated after 30 September 2026 are still being collected.
Columns
| Jan 2026 | AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 | AbelZeta | AstraZeneca | Asset sale | Legal adviser to AbelZeta (target) | Announced | 630.0 | Biotech+2 | AstraZeneca acquisition of AbelZeta's 50% share of China development and commercialisation rights to C-CAR031 |
Deals where Andrzej O’Leary is named on the firm's deal team, by the firm or the press.